Class II

Drug Recall: Terlivaz (terlipressin for injection), 0.85mg/vial, Single-Dose Vial, Rx only, Distributed by: Mallinckrodt Hospital Products Inc., Bridgewater, NJ 08807, USA, NDC 43825-200-01

Mallinckrodt Hospital Products Inc. · February 6, 2024

Reason for Recall

cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.

Distribution

USA nationwide

States Affected

NATIONWIDE

Quantity Affected

421 vials involved in this recall (2,448 vials distributed)

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0341-2024

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.